• Create Account
  • Sign In
  • My account
    Orders Downloads Address Payment methods Account details
  • SUBSCRIBE
  • SEARCH
MY ACCOUNT
  • Create Account
  • Sign In
  • My account
    Orders Downloads Address Payment methods Account details
  • SUBSCRIBE
  • SEARCH
Action Another action Something else here
logo
  • CME
  • JOURNALS
        • Journals
          • The Journal of Clinical Psychiatry
          • JCP Weekly
          • JCP Archives
          • The Primary Care Companion for CNS Disorders
          • PCC Weekly
          • PCC Archives
  • TOPICS
        • Topics
          • Addiction
          • Anxiety
          • Assessment
          • Anxiolytics
          • Bipolar
          • Complementary
          • COVID-19
          • Cultural
          • Cross Cultural Psychiatry
          • Delivery
          • Depression
          • Delivery Of Care
          • Dermatology
          • Electroconvulsive Therapy
          • End of Life Palliative Care
          • Gastroenterology
          • See all Topics
  • AUTHORS/REVIEWERS
    • Reprints and Permissions
    • Information for Authors (PCC)
    • Submit a PCC Paper
    • Information for Authors (JCP)
    • Submit a JCP Paper
    • Information for Reviewers
  • RESOURCES
    • Media Relations
    • Information for Advertisers
    • CNS Job Market
    • FAQ
Action Another action Something else here

Topics

FEATURED
Addiction Addiction
Anxiety Anxiety
Assessment Assessment
Bipolar Bipolar

A

  • Addiction
  • ADHD
  • Anxiety
  • Anxiolytics
  • Assessment
  • Autism Spectrum Disorders

B

  • Bipolar
  • Body Dysmorphic Disorder

C

  • Cancer
  • Cardiology
  • Catatonia
  • Child
  • Cognition
  • Comorbidity
  • Complementary
  • Conduct Disorders
  • Cost
  • COVID-19
  • Cross Cultural Psychiatry
  • Cultural

D

  • Delirium
  • Delivery
  • Delivery Of Care
  • Dementia
  • Depression
  • Dermatology
  • Diagnostic Tools

E

  • Eating
  • Education
  • Effects
  • Electroconvulsive Therapy
  • Encephalitis
  • End of Life Palliative Care
  • Epilepsy

F

  • Factitious Disorder
  • Fibromyalgia
  • Forensic

G

  • Gastroenterology
  • Genetics
  • Geriatric

H

  • Headache
  • Health Services
  • Hepatitis

I

  • Impulse
  • Integrated Care

J

  • Journal

M

  • Medical
  • Medical Conditions
  • Mental
  • Metabolic Disorder
  • Migraine
  • Mood Disorders
  • Movement Disorder
  • Multiple Sclerosis

N

  • Neurodevelopmental
  • Neuroimaging
  • Neuroleptic Malignant Syndrome
  • Neurologic
  • Neurology

O

  • OCD
  • Other Mental Disorders

P

  • Pain
  • Panic Disorder
  • Parkinson Disease
  • Pathological Gambling
  • Patient Physician Communication
  • Personality
  • Phobic Disorders
  • Premenstrual Dysphoric Disorder
  • Primary Care
  • Psychiatry
  • Psychopharmacology
  • Psychotherapy
  • Psychotic Disorders
  • PTSD
  • Pulmonary Disease

R

  • Renal Disease
  • Research Methods Statistics
  • Restless Legs Syndrome
  • Rheumatology

S

  • Schizophrenia
  • Seasonal Affective Disorder
  • Seizure
  • Sexual Dysfunction
  • Side Effects
  • Sleep
  • Smoking
  • Somatic
  • Somatoform Disorders
  • Stroke
  • Substance Use Disorders
  • Suicide

T

  • Tardive Dyskinesia
  • Trauma
  • Traumatic Brain Injury

U

    V

    • Veteran
    • Violence Aggression

    W

    • Weight
    • Women

    MOST POPULAR
    CASE REPORT

    Ptosis and COVID-19: An Unusual Initial Finding

    In this report, a COVID-19 case with hemiptosis is presented.

    PCC JOURNAL BASED CME

    A Patient-Centered Approach to Opioid Use Disorder

    Explore the neurobiological, psychological, psychosocial, and cultural determinants of opi...

    James K. Rustad & more
    ORIGINAL RESEARCH

    Observed Sex Differences in Cardiometabolic Indices in Patients on Antipsychotics: Secondary Analyses of a 12-Month Multicenter, Randomized, Controlled Trial

    Recognition of sex differences can promote a more personalized patient-centered care appro...

    Mark E. Schneiderhan and Xuan Li

    Sign-up to stay
    up-to-date today!

    Already registered? Sign In

    © Copyright 2021

    Physicians Postgraduate Press, Inc.
    Lifelong Learning for Clinicians

    • JCP ISSN: Online 1555-2101, Print 0160-6689
    • PCC ISSN: Online 2155-7780, Print 2155-7772
    • MedFair.com US Patent No. 684794
    • Contact Us
    • Customer Service
    • FAQ
    • About Psychiatrist.com
    • Call for Papers
    • Information for Authors (PCC)
    • Information for Authors (JCP)
    • Reprints and Permissions
    • Media
    • Advertisers
    • CNS Job Market
    • Privacy Policy
    • Unsubscribe from Elerts
    • Terms of Use
    Search Articles
    Action Another action Something else here
    click
    Hello Pop
    Baclofen, a French Exception, Seriously Harms Alcohol Use Disorder Patients Without Benefit To the Editor: Dr Andrade’s analysis of the Bacloville trial in a recent Clinical and Practical Psychopharmacology column, in which he concluded that “individualized treatment with high-dose baclofen (30-300 mg/d) may be a useful second-line approach in heavy drinkers” and that “baclofen may be particularly useful in patients with liver disease,” deserves comment.1 First, Andrade failed to recall that the first pivotal trial of baclofen, ALPADIR (NCT01738282; 320 patients, as with Bacloville), was negative (see Braillon et al2). Second, Dr Andrade should have warned readers that Bacloville’s results are most questionable, lacking robustness. Although he cited us,3 he overlooked the evidence we provided indicating that the Bacloville article4 was published without acknowledging major changes to the initial protocol, affecting the primary outcome. Coincidentally (although as skeptics, we do not believe in coincidence), the initial statistical team was changed when data were sold to the French pharmaceutical company applying for the marketing authorization in France. As Ronald H. Coase warned, “If you torture the data long enough, it will confess.”
    Related Articles
    Table Of Contents